Cytokine-like Activity of Liver Type Fatty Acid Binding Protein (L-FABP) Inducing Inflammatory Cytokine Interleukin-6.
- Author:
Hyunwoo KIM
1
;
Gaae GIL
;
Siyoung LEE
;
Areum KWAK
;
Seunghyun JO
;
Ensom KIM
;
Tam T NGUYEN
;
Sinae KIM
;
Hyunjhung JHUN
;
Somi KIM
;
Miyeon KIM
;
Youngmin LEE
;
Soohyun KIM
Author Information
- Publication Type:Original Article
- Keywords: Liver type fatty acid binding protein; Whole blood cells; End stage renal disease
- MeSH: Blood Cells; Carrier Proteins*; Cell Culture Techniques; Cell Line; DNA; Enzyme-Linked Immunosorbent Assay; Escherichia coli; Fatty Acid-Binding Proteins; Healthy Volunteers; Humans; Inflammation; Interleukin-6*; Interleukins; Kidney Failure, Chronic; Liver*; Lung
- From:Immune Network 2016;16(5):296-304
- CountryRepublic of Korea
- Language:English
- Abstract: It has been reported that fatty acid binding proteins (FABPs) do not act only as intracellular mediators of lipid responses but also have extracellular functions. This study aimed to investigate whether extracellular liver type (L)-FABP has a biological activity and to determined serum L-FABP levels in patients with end-stage renal disease (ESRD). We isolated L-FABP complementary deoxyribonucleic acid (cDNA) from the Huh7 human hepatocarcinoma cell line and expressed the recombinant L-FABP protein in Escherichia coli. A549 lung carcinoma and THP-1 monocytic cells were stimulated with the human recombinant L-FABP. Human whole blood cells were also treated with the human recombinant L-FABP or interleukin (IL)-1α. IL-6 levels were measured in cell culture supernatants using IL-6 enzyme-linked immunosorbent assay (ELISA). Human recombinant L-FABP induced IL-6 in a dose-dependent manner in A549, THP-1 cells, and whole blood cells. The blood samples of healthy volunteers and patients with ESRD were taken after an overnight fast. The serum levels of L-FABP in healthy volunteers and ESRD patients were quantified with L-FABP ELISA. The values of L-FABP in patients with ESRD were significantly lower than those in the control group. Our results demonstrated the biological activity of L-FABP in human cells suggesting L-FABP can be a mediator of inflammation.
